Form 8-K - Current report:
SEC Accession No. 0001159036-25-000022
Filing Date
2025-05-02
Accepted
2025-05-02 16:07:44
Documents
14
Period of Report
2025-05-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K halo-20250501.htm   iXBRL 8-K 43145
5 GRAPHIC halo-20250501_g1.jpg GRAPHIC 15840
  Complete submission text file 0001159036-25-000022.txt   195511

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20250501.xsd EX-101.SCH 1798
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20250501_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20250501_pre.xml EX-101.PRE 12522
16 EXTRACTED XBRL INSTANCE DOCUMENT halo-20250501_htm.xml XML 2712
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 25908491
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)